Back to Journals » OncoTargets and Therapy » Volume 14

GATA1 Gene Silencing Inhibits Invasion, Proliferation and Migration of Cholangiocarcinoma Stem Cells via Disrupting the PI3K/AKT Pathway [Retraction]

Authors Shi G, Zhang H, Yu Q, Hu C, Ji Y

Received 4 February 2021

Accepted for publication 4 February 2021

Published 12 February 2021 Volume 2021:14 Pages 1005—1006

DOI https://doi.org/10.2147/OTT.S305322


Shi G, Zhang H, Yu Q, Hu C, Ji Y. Onco Targets Ther.  2019;12:5335— 5354.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article.

The journal was notified of potential image manipulation in Figure 4D:
● Figure 4D 0 h panel GATA1 appears to show partial duplication with Figure 4D 0 h panel si-GATA1.
● Figure 4D 0 h si-GATA appears to show partial duplication with Figure 4D 0 h panel LY294002.

The authors could not provide the satisfactory raw data for the study and the Editor has determined the findings are no longer valid and requested for the paper to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Shi G, Zhang H, Yu Q, Hu C, Ji Y. Onco Targets Ther. 2019;12:5335—5354.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article.

The journal was notified of potential image manipulation in Figure 4D:

  • Figure 4D 0 h panel GATA1 appears to show partial duplication with Figure 4D 0 h panel si-GATA1.
  • Figure 4D 0 h si-GATA appears to show partial duplication with Figure 4D 0 h panel LY294002.

The authors could not provide the satisfactory raw data for the study and the Editor has determined the findings are no longer valid and requested for the paper to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]